Michael Ryan from Boston Scientific explained, "We consider ourselves a strategic investor. For us to invest in a company, three things need to be true: it needs to be an investment-grade asset with a great team and technology, it must be available at terms that provide the potential for financial return, and it needs to operate in a space that is a strategic fit for one of our six operating units.